RNS Number : 4064U
Legal & General UCITS ETF PLC
29 July 2020
| Funds |
Date |
ISIN code |
Shares in Issue |
Currency |
Net Asset Value |
NAV/per share Base |
| L&G US Equity UCITS ETF |
28/07/2020 |
IE00BFXR5Q31 |
11767267 |
USD |
142876608.33 |
12.142 |
| L&G UK Equity UCITS ETF |
28/07/2020 |
IE00BFXR5R48 |
1200000 |
GBP |
10871981.83 |
9.060 |
| L&G Global Equity UCITS ETF |
28/07/2020 |
IE00BFXR5S54 |
2900000 |
USD |
34017476.79 |
11.730 |
| L&G Japan Equity UCITS ETF |
28/07/2020 |
IE00BFXR5T61 |
11185000 |
USD |
120743936.92 |
10.795 |
| L&G Europe ex UK Equity UCITS ETF |
28/07/2020 |
IE00BFXR5V83 |
9360988 |
EUR |
102566410.94 |
10.957 |
| L&G Asia Pacific ex Japan Equity UCITS ETF |
28/07/2020 |
IE00BFXR5W90 |
4981427 |
USD |
53050225.90 |
10.650 |
| L&G Clean Water UCITS ETF |
28/07/2020 |
IE00BK5BC891 |
1500000 |
USD |
16444433.63 |
10.963 |
| L&G Artificial Intelligence UCITS ETF |
28/07/2020 |
IE00BK5BCD43 |
7946000 |
USD |
105967152.20 |
13.336 |
| L&G Healthcare Innovation UCITS ETF |
28/07/2020 |
IE00BK5BC677 |
3000000 |
USD |
40582158.31 |
13.527 |
| L&G Pharma Breakthrough UCITS ETF |
28/07/2020 |
IE00BF0H7608 |
2150000 |
USD |
25911476.34 |
12.052 |
| L&G Europe Equity (Responsible Exclusions) UCITS ETF |
28/07/2020 |
IE00BKLTRN76 |
9200000 |
EUR |
95206089.87 |
10.348 |
| L&G US Equity (Responsible Exclusions) UCITS ETF |
28/07/2020 |
IE00BKLWY790 |
57800000 |
USD |
631932584.25 |
10.933 |
| L&G Battery Value-Chain UCITS ETF |
28/07/2020 |
IE00BF0M2Z96 |
13200000 |
USD |
137786988.85 |
10.438 |
| L&G Ecommerce Logistics UCITS ETF |
28/07/2020 |
IE00BF0M6N54 |
9600000 |
USD |
108789352.11 |
11.332 |
| L&G ROBO Global Robotics and Automation UCITS ETF |
28/07/2020 |
IE00BMW3QX54 |
47030616 |
USD |
856778820.34 |
18.217 |
| L&G Cyber Security UCITS ETF |
28/07/2020 |
IE00BYPLS672 |
82611776 |
USD |
1621724566.49 |
19.631 |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
NAVMZGZNFRVGGZZ
